Fifteen brokerages covering C3.ai have delivered a consensus recommendation of “Reduce,” including five sell ratings, seven holds, two buys and one strong buy. The average 12-month target among these analysts stands at $21.92, implying a potential upside of nearly 60% relative to recent trading levels. Notably, UBS raised its neutral target to $17.00 in September, while Wedbush continues to rate the shares as “Outperform” with a $20.00 objective. This divergence underscores a polarized outlook among Wall Street firms on C3.ai’s near-term growth prospects and valuation support.

For the twelve months ended last quarter, C3.ai reported revenue of $389.1 million and a net loss of $288.7 million, translating to a net margin of negative 108.1%. Return on equity and return on assets both remain deeply negative at 46.5% and 37.9%, respectively. These figures highlight the company’s ongoing challenge to scale its enterprise AI platform profitably despite revenue growth, as high R&D and sales expenses continue to outpace top-line gains.

Institutional investors hold 39.0% of C3.ai’s outstanding shares, signaling significant confidence from large asset managers and hedge funds in the company’s long-term AI platform vision. Insiders retain 26.5% ownership, even after senior executives disclosed sales totaling nearly 1.95 million shares valued at approximately $30.8 million over the past quarter. This insider selling has reduced executive stakes by roughly one-fifth, yet still positions management as material shareholders aligned with strategic execution.

C3.ai’s software subscription and services revenue of $389.1 million supports a price-to-sales ratio of 4.96x based on current equity value. The company generated $75.2 million in Q3 top-line, slightly beating expectations, but saw year-over-year revenue decline of 20.3%. Adjusted losses per share of $0.25 outperformed analyst forecasts by $0.08. While the 4.96x sales multiple reflects a discount to many enterprise software peers, it remains elevated given the company’s sustained unprofitable status and recent deceleration in revenue growth.